Thus, by using an established GBM cell line and primary cells isolated from a human tumor sample, we can reproduce a NMDAR-dependent induction of cFos expression by using Top2β as a common phenomenon in GBM cells, which might constitute a key aspect of glioblastoma biology and therapy, including tumorigenicity and therapeutic resistance. This evidence concerns the gene FOS and glioblastoma.